封面
市場調查報告書
商品編碼
1535659

婦科器材市場 - 按產品、最終用途 - 全球預測

Gynecological Devices Market - By Product, End-use - Global Forecast 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於婦科疾病和疾病的盛行率不斷上升,2024 年至 2032 年間,婦科器材市場規模預計將達到 8.1% 的複合年成長率。子宮內膜異位症、多囊性卵巢症候群 (PCOS) 和子宮頸癌等疾病變得越來越常見,進一步推動了對診斷和治療設備的更高需求。據報道,每 10 名女性中就有 1 名患有多囊性卵巢症候群。

技術進步,例如微創手術和複雜成像技術的發展,也促進了市場的成長。健康計劃和教育計劃強調定期婦科檢查和早期發現以尋求醫療護理和使用先進婦科設備的重要性。數位醫療技術和遠距醫療的日益普及也擴大了婦科護理的範圍,進一步推動了產品需求。

婦科器械產業分為產品、最終用途和地區。

從產品來看,診斷影像系統領域的市場規模預計將在 2032 年之前持續成長,因為它在婦科疾病的早期檢測和精確診斷中發揮關鍵作用。超音波、磁振造影 (MRI) 和電腦斷層掃描 (CT) 等先進影像技術可以實現生殖器官的詳細可視化,有助於準確評估卵巢囊腫、子宮肌瘤和癌症等疾病。

就最終用途而言,預計到 2032 年,門診手術中心領域的婦科器械行業將取得顯著成長。門診手術中心 (ASC) 進一步專注於提供當日手術護理,包括微創婦科手術,以減少住院需求並降低整體醫療費用。

由於醫療基礎設施投資的增加和醫療服務的擴展,到 2032 年,亞太地區婦科設備市場規模將大幅成長。該地區的政府和私人實體正在加強其醫療保健設施,特別是在印度和中國等新興經濟體,以改善獲得先進婦科護理的機會。可支配收入的增加和人們對醫療保健意識的增強也導致對專業婦科治療和設備的需求增加,從而促進了區域市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 婦科疾病盛行率上升
      • 加強常規檢查宣傳力度
      • 引進技術先進的產品
    • 產業陷阱與挑戰
      • 替代療法的採用率增加
  • 成長潛力分析
  • 報銷場景
  • 監管環境
  • 技術景觀
    • 核心技術
    • 鄰近技術
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 手術器械
    • 婦科內視鏡設備
      • 子宮腔鏡
      • 陰道鏡
      • 電切鏡
      • 腹腔鏡
      • 內視鏡成像系統
    • 子宮內膜移除裝置
      • 水熱消融裝置
      • 射頻消融設備
      • 球囊消融裝置
      • 其他子宮內膜移除裝置
    • 流體管理系統
    • 女性絕育/避孕器具
      • 永久節育
      • 子宮內避孕器 (IUD)
      • 陰道內環
      • 皮下植入避孕藥
  • 手持式儀器
    • 陰道窺器
    • 特納庫魯姆
    • 刮匙
    • 套管針
    • 切片鉗
    • 其他手持式儀器
  • 診斷影像系統

第 6 章:市場估計與預測:按最終用途分類,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心
  • 診斷中心
  • 其他最終用戶

第 7 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 8 章:公司簡介

  • Abbott Laboratories
  • Bayer AG
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson (Ethicon, Inc.)
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
簡介目錄
Product Code: 9822

Gynecological devices market size is poised to witness 8.1% CAGR between 2024 and 2032 driven by the increasing prevalence of gynecological disorders and diseases. Conditions, such as endometriosis, polycystic ovary syndrome (PCOS), and cervical cancer are becoming more common, further prompting the higher demand for diagnostic and therapeutic devices. As per reports, 1 in every 10 women suffer from PCOS.

Technological advancements, such as the development of minimally invasive procedures and sophisticated imaging techniques, are also contributing to the market growth. Health initiatives and educational programs are emphasizing the importance of regular gynecological check-ups and early detection for seeking medical attention and utilizing advanced gynecological devices. The rising adoption of digital health technologies and telemedicine has also expanded access to gynecological care, further boosting the product demand.

The gynecological devices industry is classified into product, end-use, and region.

Based on product, the market size from the diagnostic imaging systems segment is anticipated to witness growth through 2032 due to its critical role in the early detection and precise diagnosis of gynecological conditions. Advanced imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are enabling the detailed visualization of the reproductive organs for facilitating accurate assessments of disorders like ovarian cysts, fibroids, and cancers.

In terms of end-use, the gynecological devices industry from the ambulatory surgical centers segment is predicted to record notable gains up to 2032. This is owing to the rising preference for outpatient surgical procedures to offer convenience and cost-effectiveness. Ambulatory surgical centers (ASCs) further specialize in providing same-day surgical care, including minimally invasive gynecological procedures to reduce the need for hospital admissions and lower the overall healthcare costs.

Asia Pacific gynecological devices market size will grow significantly through 2032 attributed to the increasing investments in healthcare infrastructure and the expansion of healthcare services. Governments and private entities in the region are enhancing their healthcare facilities, particularly in emerging economies like India and China to improve access to advanced gynecological care. The rising disposable incomes and the growing healthcare awareness among the population are also leading to higher demand for specialized gynecological treatments and devices, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of gynecological disorders
      • 3.2.1.2 Increase in initiatives promoting routine checkup
      • 3.2.1.3 Introduction of technically advanced products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increase in adoption of alternate therapies
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
  • 3.5 Regulatory landscape
  • 3.6 Technological landscape
    • 3.6.1 Core technologies
    • 3.6.2 Adjacent technologies
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Surgical devices
    • 5.2.1 Gynecological endoscopy devices
      • 5.2.1.1 Hysteroscope
      • 5.2.1.2 Colposcope
      • 5.2.1.3 Resectoscope
      • 5.2.1.4 Laparoscope
      • 5.2.1.5 Endoscope imaging systems
    • 5.2.2 Endometrial ablation devices
      • 5.2.2.1 Hydrothermal ablation devices
      • 5.2.2.2 Radiofrequency ablation devices
      • 5.2.2.3 Balloon ablation devices
      • 5.2.2.4 Other endometrial ablation devices
    • 5.2.3 Fluid management systems
    • 5.2.4 Female sterilization/contraceptive devices
      • 5.2.4.1 Permanent birth control
      • 5.2.4.2 Intra uterine devices (IUD)
      • 5.2.4.3 Intravaginal rings
      • 5.2.4.4 Subdermal contraceptive implants
  • 5.3 Handheld instruments
    • 5.3.1 Vaginal speculum
    • 5.3.2 Tenaculum
    • 5.3.3 Curettes
    • 5.3.4 Trocars
    • 5.3.5 Biopsy forceps
    • 5.3.6 Other handheld instruments
  • 5.4 Diagnostic imaging systems

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospital and clinics
  • 6.3 Ambulatory surgery centers
  • 6.4 Diagnostic centers
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
  • 8.2 Bayer AG
  • 8.3 Boston Scientific Corporation
  • 8.4 CooperSurgical, Inc.
  • 8.5 Fresenius Medical Care AG & Co. KGaA
  • 8.6 Hologic, Inc.
  • 8.7 Intuitive Surgical, Inc.
  • 8.8 Johnson & Johnson (Ethicon, Inc.)
  • 8.9 Karl Storz SE & Co. KG
  • 8.10 Medtronic plc
  • 8.11 Olympus Corporation
  • 8.12 Richard Wolf GmbH
  • 8.13 Smith & Nephew plc
  • 8.14 Stryker Corporation
  • 8.15 Zimmer Biomet Holdings, Inc.